Press release
Pharmacy OneSource Announces Free Webinar on Health Care Reform
How new regulations will drive hospitals to improve quality patient careBellevue, WA – Pharmacy OneSource, software-as-a-service provider of Sentri7, a real-time patient surveillance, documentation and reporting system, is pleased to announce a complimentary webinar presented by Steve Riddle, BS Pharm, BCPS, FASHP, and Tom Jordan, RN, BS, CIC on "The Impact of Health Care Reform on Hospitals: Rising to the Occasion to Improve Care."
Health care reform has arrived via HR 3590, The Patient Protection and Affordable Care Act. Numerous changes will be rolling out over the health care landscape in the coming years. Key areas of focus include expansion of hospital quality measures, increasing focus on hospital-acquired infections and conditions, reducing hospital readmissions and incorporating patient satisfaction as measured by the HCHAPS survey. For the first time, hospital reimbursement by CMS will be tied to performance related to these indicators. In addition, greater emphasis will be placed on coordination of care both within the hospital and for care transitions related to admissions, transfers and discharges.
Riddle and Jordan will discuss the content of HR3590 and the demands it will place on hospitals. Opportunities for infection preventionists and pharmacists to demonstrate their value in driving quality improvement processes and improving patient outcomes will be shared.
The Impact of Health Care Reform on Hospitals: Rising to the Occasion to Improve Care
DATE: Wednesday, October 13, 2010
TIME: 1:00 PM - 2:00 PM EDT
WHERE: http://www.pharmacyonesource.com/webinars
About the Presenters: Steve Riddle, BS Pharm, BCPS, FASHP, currently serves as the VP of Clinical Affairs for Pharmacy OneSource. Riddle serves on the CMS-appointed Hospital Outpatient Quality Measures Technical Expert Panel and is a member of the ASHP Quality Improvement Initiative Expert Panel. He has 24 years of pharmacy experience in clinical practice settings, including internal medicine, critical care, bone marrow transplant, renal transplant and acute and chronic cardiovascular care management.
Tom Jordan, RN, BS, CIC, has more than 25 years of experience as a registered nurse. Prior to becoming an infection preventionist, he worked in pediatric intensive care, trauma nursing, and employee health. He has 20 years experience in acute care infection prevention. He has been an APIC member for many years and has contributed articles to Advance for Nurses and Nursing Spectrum.
About Pharmacy OneSource (www.pharmacyonesource.com)
Pharmacy OneSource is healthcare's #1 Software-as-a-Service (SaaS) provider. Our more than 80 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services: Accupedia, Amplifi, MedBoard, Quantifi, ScheduleRx, Sentri7, Simplifi 797, and VeriForm.
Pharmacy OneSource
3535 Factoria Blvd. SE #440
Bellevue, WA 98006
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacy OneSource Announces Free Webinar on Health Care Reform here
News-ID: 146465 • Views: …
More Releases from Pharmacy OneSource
Richie's Specialty Pharmacy Selects Simplifi 797 for USP 797 Compliance
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Richie's Specialty Pharmacy, LLC has selected its Simplifi 797 software for achieving sterile compounding compliance.
Simplifi 797 is a web-based application that automates, integrates and streamlines quality activities and documentation related to U.S. Pharmacopeia's Chapter 797 guidelines. The software manages task scheduling for environmental monitoring and automates the reporting of exceptions and compliance.
"Simplifi…
Pharmacy OneSource® Partners with CriticalPoint™ to Offer the Next Generation …
Bellevue, Washington – Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Pharmacy OneSource® has released a new version of Simplifi 797®, a web-based quality assurance software for USP chapter 797 compounding compliance.
The upgraded version of Simplifi 797 includes CriticalPoint's education program, which gives users unlimited access to 42 hours of ACPE-approved continuing education credits supporting compliance with USP Chapter . Lessons…
Wolters Kluwer Health Unveils Integration between UpToDate and Sentri7
Bellevue, WA -- Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that UpToDate's clinical knowledge system has been integrated with Sentri7 surveillance software by Pharmacy OneSource.
This partnership of evidence-based clinical information through UpToDate and clinical patient surveillance from Sentri7 offers healthcare providers actionable information at the point of care to make better decisions in directing patient care.
UpToDate synthesizes the most recent medical…
More Releases for Pharm
Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031.
The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both…
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is…
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral…
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations…
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the…